Umicore 1H 2010
Forits 1H 2010, Umicore has reported revenues of €987.1 M (€860.2 M for its 1H 2009), recurring EBIT of €186.3 M (€49.5 M), EBITDA of €244.3 M (€111.6 M), basie EPS of €1.24 (€0.18), R&D expenditure of €66.2 M (6% of revenues), and Capital expenditure of €75.5 M. An interim dividend of €0.325 will be paid in Oct 2010. There was recovery in the company’s Advanced Materials and Predous Metals Products & Catalysts businesses and a positive impact of cost reduction measures.
Meuse-Rhine Journal. 15 Aug 2010, (236)
(Wadsworth & Wadsworth Assoc. PO Box 42. NL-6245 ZG. Eijsden. The Netherlands. Tel: +31 43 4093719 Fax: »31 43 4098899. Website: http://www.meuse-rhine-joumal.com)
UNPZ selects CDTech for gasoline desulfurization unit
OAO UNPZ has commissioned Catalytic Distiilation Technologies (CDTech) to provide licence and basie engineering services for a fluid-catalytic-cracking gasoline hydro-desulfurization plant in Russia. The facility will have a design processing capacity of 1.26 M tonne/y.
Chemical Engineering (New York). Aug 2010.117 (8). 51
U0P Technology selected to support conversion of biomass to fuel at California Renewable Energy facility
UOP LLC has announced that its technology was selected for use in Rentech lnc’s Rialto Renewable Energy Center for the conversion of biomass to transporiation fuels. The renewable energy center, to be built in Rialto, CA, will convert biomass, such as yard and tree trimmings, into renewable, ultra-clean diesel fuel and renewable electricity. The new facility will use UOP hydroprocessing technology, which converts hydrocarbons into clean-fuel produets. The center is expected to produce roughly 640 bbl/ day of liguid fuel and 35 MW of base-load electricity, enough to power about 30,000 homes each day. In Aug 2009, eight airlines signed a multi-year agreement with Rentech to together purchase up to 1.5 M gallon/y of diesel from the Rialto Project for use in ground service eguipment at Los Angeles
International Airport. The Rialto Project is scheduled to start up in late 2012.
Press release from: UOP UC. 25 East Algonquin Road. Des Plaines.IL600175017.USA. Tel: +1 847 391 2000. Webs4e: http://www.uop.com (1 Sep 2010)
Verenium closes sale of cellulosic biofuels business to BP
Verenium Corp announced the closing of the sale of its cellulosic biofuels business to BP Biofuels North America (BP) for $98.3 M, subject to the additional financial terms of the transaction announced on 15 Jul 2010. In the transaction, BP acquired the company's facilities in Jennings, LA. including the pilot plant and demonstration-scale facility, the San Diego, CA, R&D facilities, as well as cellulosic biofuels and cellulosic enzyme technology and related IP. In addition, BP retained select personnel needed to continue the cellulosic biofuels development programme. BP also became the sole owner of Verdpia Biofuels and Galaxy Biofuels, the 50-50 jvs created by the company and BP. Verenium retains its commerdal enzyme business, including its biofuels enzyme produets. and has the right to develop its own cellulosic enzyme programme. Verenium also retains select R&D capabilities, as well as the potential option to access select biofuels technology developed by BP using the technology acquired from Verenium through this transaction.
Press release trem Veremum Corp 55 Camfcrdge Parkway, Cambridge, MA 02142, USA. Tel: *1 617 674 5300. Website: http7/www.\eremjm.com (2 Sep 2010)
Verenium reports financial results for the 2Q 2010
Verenium Corp reported finandal results for 2Q and 1H ended Jun 2010. The company also provided a summary of recent highlights and financial guidance for 2010. Total revenues for 2Q 2010 were $20.0 M ($16.3 M in 2Q 2009), with product revenues representing morę than 60% of total revenues in both periods. Product revenues for 2Q and 1H 2010 inereased to $13.3 M and $24.9 M, respectively. ($10.5 M in 2Q 2009 and $21.1 M in 1H 2009), primarily due to an inerease in Phyzyme profit share from Danisco, as well as an inerease in revenues from Veretase and
Xylathin enzymes, which continued to gain acceptance in the grain ethanol markets, and Purifine enzyme for the soybean oil processing market. Fuelzyme revenues retumed to levels achieved in 1Q 2009, indicating recovery in the com ethanol market. R&D expenses were $12.975 M for 2Q 2010 ($16.132 M in 2Q 2009). Net loss attributed to Verenium for 2Q 2010 was $4.5 M (net loss of $20.0 M in 2Q 2009), on a GAAP accounting basis. For 1H 2010 R&D expenses were $29.974 M (S33.947M in 1H
2009) and net loss attributed to Verenium was $16.481 M for 1H 2010 (net loss attributed to Verenium of $16.641 M for 1H 2009).
Verenium financial results 20 and 1H 2010,9 Aug 2010 (Iftrenium Corp. 55 Cambridge Parkway, Cambridge. MA 02142. USA. Tel: *1 617 674 5300. Website: http ://www.verenium,com)
WR Grace reports 2Q 2010 results: Grace Davison: segment operating income up 30%
For its 2Q 2010 (period ends 30 Jun
2010) , the Grace Davison segment of WR Grace & Co has reported net sales of $453.9 M ($477.9 M for its 2Q 2009), of which: Refining Technologies accounted for S179.1 M (S246.9 M). Materials Technologies $174.1 M ($146.9 M), and Speciality Technologies $100.7 M ($84.1 M); and adjusted EBIT of $106.5 M ($81.8 M). For its 1H 2010, this segment has reported net sales of $872.2 M ($955.8 M for its 1H 2009), of which: Refining Technologies accounted for $351.1 M ($5213.7 M). Materials Technologies $335.1 M ($280.9 M). and Speciality Technologies $186.0 M ($151.2 M); and adjusted EBIT of $194.3 M (S121.8 M).
WR Grace Results 20 2010. 22 Jul 2010,3-5.14 (WR Grace & Co. 7500 Grace Drwe. Cokimba, MD 21044. USA. Website: http://www.grace.com)
WR Grace plots exit strategy
WR Grace expects to emerge from Chapter 11 bankruptcy protection in 4Q 2010. The company has released an investor presentation highlighting financial targets through 2013, including 20% company-wide adjusted EBITDA margins, sales growth of 8-10%/y. EBITDA growth forecast for full-year 2010 is 16-16.4%. Grace has been awaiting finał court approval for its reorganization
OCTOBER 2010 5